Leading edge technologies for faster, more effective clinical trials

With the spiralling cost of bringing new drugs to market, the pharmaceutical industry needs innovative techniques to improve their efficiency, lowering development costs and reducing the time taken to bring a drug to market. Since 1998, Tessella has been helping to drive improvements in drug development through technology in areas such as:

Adaptive Clinical Trials

The use of Adaptive Clinical Trials is a new and rapidly developing field, which offers potentially huge benefits to drug development programs. Tessella are leaders in Adaptive Clinical Trials technology, with experience from inception through to execution. See our Case Studies for more details and to read about Tessella’s ACT offerings.

Supply Forecasting Tool

Drug supply in clinical trials is an increasingly complex operation, made harder by the introduction of Adaptive Clinical Trial designs, which require central randomization and vary the allocation of subjects to different treatment arms in an unpredictable way. Using our experience in advanced statistical modelling and Adaptive Clinical Trials, we have produced the Tessella Supply Forecasting Tool (SFT) a unique tool in the market place that allows users to improve both the planning and execution of drug supply to a trial. See our SFT pages.

Clinical Trials Support

Many of the techniques and experience we have developed to support our work in Adaptive Clinical Trials can be applied to more traditional trial methodologies. Although this market is well-catered for by off-the-shelf products and CROs, Tessella’s ability to develop customized systems quickly and flexibly can provide cheaper solutions for specific problems. For example, read about our Targit project.